Profitability Ratios
| Ratio |
Value |
| GP Margin |
71.3% |
| EBIT Margin |
-3.7% |
| EBITDA Margin |
-1.0% |
| Operating Margin |
-3.7% |
| Pretax Margin |
-1.5% |
| Cont. Ops Margin |
-4.8% |
| Net Margin |
-4.8% |
| Bottom Line Margin |
-4.8% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
4.69 |
| Quick Ratio |
4.22 |
| Solvency Ratio |
-0.141 |
| Cash Ratio |
2.08 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.01 |
| Forward PEG |
0.01 |
| Price/Book |
0.59 |
| Price/Sales |
0.30 |
| Price/FCF |
93.90 |
| Price/Op Cash Flow |
17.09 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0653 |
| Debt/Equity |
0.0844 |
| Debt/Capital |
0.0778 |
| Long-Term Debt/Capital |
0.0297 |
| Financial Leverage |
1.29 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
2.50 |
| Operating Cash Flow Ratio |
0.160 |
| Operating Cash Flow/Sales |
1.8% |
| Free Cash Flow/Operating Cash Flow |
18.2% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-3.64 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
1.49 |
| Operating Cash Flow Coverage |
0.41 |
| Capital Expenditure Coverage |
1.22 |
| Dividend + Capital Expenditure Coverage |
1.18 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
-1.0443% |
| Dividend Yield |
0.1663% |
| Dividend Yield % |
0.1663% |
| Dividend Per Share |
0.0178 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
35.13 |
| EPS |
-1.700 |
| Debt/Share |
1.5285 |
| Cash/Share |
15.23 |
| Book Value/Share |
18.11 |
| Tangible BV/Share |
18.11 |
| Equity/Share |
18.11 |
| Operating Cash Flow/Share |
0.625 |
| Capital Expenditure/Share |
0.511 |
| FCF/Share |
0.114 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
3.311 |
| Earnings Before Tax/EBIT |
0.397 |
| Price/Fair Value |
0.59 |
| Debt/Market Cap |
0.0912 |
| Effective Tax Rate |
-231.1% |
| Enterprise Value Multiple |
-12.05 |
MED - Medifast, Inc.